Skip to main content
Clinical studies· 5 min read

Norway: the experience of a private clinic

24 people with no symptoms, three level ranges and around four years of medical follow-up.¹

The context

Between January and March 2020, a private clinic in Norway offered hPG80 testing to 24 people over 50 who had no symptoms or suspected cancer.¹

A village beside a Norwegian fjord
In Norway, preventive follow-up at a private clinic.

Nine people were considered at increased risk: a first-degree relative with a history of cancer, a personal history of cancer or more than 20 years of smoking. The other 15 were considered at average risk.¹

Follow-up lasted around four years, until late 2024 or early 2025.¹

The test results

Of the 24 people tested, 16 had a low level, four an intermediate level and four a high level.¹

People with intermediate or high levels underwent further examinations and medical follow-up tailored to their circumstances.¹

Four follow-up stories

The examinations and follow-up identified cancers in people with intermediate or high levels. Here are the four care journeys reported in the publication, without the individuals' names.¹

A doctor talking with a female patient in a bright consulting room
Personalized follow-up for people with intermediate or high levels.

In these cases, the hPG80 level was considered alongside other medical information to guide examinations and follow-up.¹

Lung cancer: a high hPG80 level guides further examinations, with no recurrence after 4 years.

A 60-year-old man had a high level. Lung nodules had initially been considered benign. The high level led to a PET-CT scan, followed by surgery in July 2020.¹

A carcinoid tumour of the lung was completely removed, with no lymph node involvement. No recurrence was observed after four years.¹

Colon cancer found during a colonoscopy

A 65-year-old woman with a family history of cancer and an intermediate level underwent a colonoscopy that revealed colon cancer.¹

She had surgery followed by additional treatment. After treatment, her hPG80 level fell back below the threshold. No recurrence was observed after four years.¹

Prostate cancer found during a procedure

A 63-year-old man, two of whose relatives had had cancer, had an intermediate level. Prostate cancer was found during a procedure planned for urinary problems, even though the ultrasound and PSA results had not raised concerns.¹

His hPG80 level fell back below the threshold. No recurrence was observed after four years.¹

Two lung cancers treated in 2024

A 71-year-old man had a high level. A CT scan requested because of this level showed a kidney cyst, which was subsequently removed.¹

Two lung cancers were found in 2024 and treated. Eleven months after they were found, he had no signs of disease.¹

What follow-up shows

Everyone in whom cancer was found was alive at follow-up, with no recurrence.¹

No cancer was found during the four years of follow-up among the 16 people with low levels. In four people with intermediate or high levels, the examinations found nothing.¹

The publication suggests regular monitoring of the level, annually for people at increased risk. The test does not locate a possible cancer: further examinations are guided by the doctor. It remains complementary to organized screening programmes and does not replace them.¹

Prevonco

Prevonco is currently available in France only.

An aid to the early detection of 16 cancers

No prescription needed, for people without symptoms. If you have an unexplained symptom, see your doctor first.

Pre-register for free →